Consonance Capital

Consonance Capital Management as of March 31, 2017

Portfolio Holdings for Consonance Capital Management

Consonance Capital Management holds 24 positions in its portfolio as reported in the March 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Horizon Pharma 9.6 $92M 6.2M 14.78
United Therapeutics Corporation (UTHR) 9.1 $87M 642k 135.38
Globus Med Inc cl a (GMED) 9.1 $87M 2.9M 29.62
Clovis Oncology 8.9 $85M 1.3M 63.67
Amarin Corporation (AMRN) 8.4 $80M 25M 3.20
Mallinckrodt Pub 7.3 $70M 1.6M 44.57
Myriad Genetics (MYGN) 6.0 $57M 3.0M 19.20
Corcept Therapeutics Incorporated (CORT) 5.9 $57M 5.2M 10.96
AtriCure (ATRC) 5.8 $55M 2.9M 19.15
Advanced Accelerat spon ads each rep 2 ord 5.5 $52M 1.3M 39.86
Pacira Pharmaceuticals (PCRX) 4.7 $44M 973k 45.60
La Jolla Pharmaceuticl Com Par 4.4 $42M 1.4M 29.85
Retrophin 4.1 $39M 2.1M 18.46
Novadaq Technologies 2.5 $24M 3.0M 7.79
Corindus Vascular Robotics I 2.1 $20M 15M 1.31
Acadia Healthcare (ACHC) 1.4 $14M 311k 43.60
Acorda Therapeutics 1.4 $13M 619k 21.00
Array BioPharma 1.3 $12M 1.4M 8.94
Vericel (VCEL) 0.9 $8.4M 3.0M 2.80
Biosante Pharmaceuticals (ANIP) 0.7 $7.1M 143k 49.51
Adma Biologics (ADMA) 0.7 $6.2M 1.3M 4.88
Biolase Technology 0.2 $1.7M 1.3M 1.35
Seaspine Holdings 0.1 $692k 88k 7.85
Strongbridge Bioph shs usd 0.0 $48k 10k 4.80